Annual CFI
-$362.00 K
-$54.40 M-100.67%
31 December 2023
Summary:
Verrica Pharmaceuticals annual cash flow from investing activities is currently -$362.00 thousand, with the most recent change of -$54.40 million (-100.67%) on 31 December 2023. During the last 3 years, it has risen by +$3.22 million (+89.89%). VRCA annual CFI is now -100.67% below its all-time high of $54.04 million, reached on 31 December 2022.VRCA Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
-$16.00 K
-$5000.00-45.45%
30 September 2024
Summary:
Verrica Pharmaceuticals quarterly cash flow from investing activities is currently -$16.00 thousand, with the most recent change of -$5000.00 (-45.45%) on 30 September 2024. Over the past year, it has increased by +$49.00 thousand (+75.38%). VRCA quarterly CFI is now -100.04% below its all-time high of $43.01 million, reached on 31 March 2022.VRCA Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$254.00 K
+$49.00 K+16.17%
30 September 2024
Summary:
Verrica Pharmaceuticals TTM cash flow from investing activities is currently -$254.00 thousand, with the most recent change of +$49.00 thousand (+16.17%) on 30 September 2024. Over the past year, it has dropped by -$6.87 million (-103.84%). VRCA TTM CFI is now -100.46% below its all-time high of $55.52 million, reached on 30 June 2022.VRCA TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VRCA Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -100.7% | +75.4% | -103.8% |
| 3 y3 years | +89.9% | -100.3% | +95.7% |
| 5 y5 years | +99.5% | +99.2% | +86.2% |
VRCA Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -100.7% | +89.9% | -100.0% | +93.0% | -100.5% | +95.7% |
| 5 y | 5 years | -100.7% | +99.5% | -100.0% | +99.9% | -100.5% | +99.3% |
| alltime | all time | -100.7% | +99.5% | -100.0% | +100.0% | -100.5% | +99.7% |
Verrica Pharmaceuticals Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$16.00 K(+45.5%) | -$254.00 K(-16.2%) |
| June 2024 | - | -$11.00 K(<-9900.0%) | -$303.00 K(-13.7%) |
| Mar 2024 | - | $0.00(-100.0%) | -$351.00 K(-3.0%) |
| Dec 2023 | -$362.00 K(-100.7%) | -$227.00 K(+249.2%) | -$362.00 K(-105.5%) |
| Sept 2023 | - | -$65.00 K(+10.2%) | $6.62 M(-24.4%) |
| June 2023 | - | -$59.00 K(+436.4%) | $8.75 M(-20.6%) |
| Mar 2023 | - | -$11.00 K(-100.2%) | $11.02 M(-79.6%) |
| Dec 2022 | $54.04 M(-5514.9%) | $6.75 M(+226.4%) | $54.04 M(+5.3%) |
| Sept 2022 | - | $2.07 M(-6.2%) | $51.30 M(-7.6%) |
| June 2022 | - | $2.21 M(-94.9%) | $55.52 M(+78.1%) |
| Mar 2022 | - | $43.01 M(+972.4%) | $31.18 M(-3224.2%) |
| Dec 2021 | -$998.00 K(-72.1%) | $4.01 M(-36.2%) | -$998.00 K(-83.0%) |
| Sept 2021 | - | $6.29 M(-128.4%) | -$5.87 M(-83.8%) |
| June 2021 | - | -$22.14 M(-304.3%) | -$36.28 M(+229.3%) |
| Mar 2021 | - | $10.84 M(-1362.8%) | -$11.02 M(+207.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | -$3.58 M(-113.8%) | -$858.00 K(-96.4%) | -$3.58 M(-191.1%) |
| Sept 2020 | - | -$24.13 M(-870.8%) | $3.93 M(-84.9%) |
| June 2020 | - | $3.13 M(-82.9%) | $26.03 M(+12.4%) |
| Mar 2020 | - | $18.27 M(+174.8%) | $23.16 M(-10.8%) |
| Dec 2019 | $25.95 M(-132.5%) | $6.65 M(-427.9%) | $25.95 M(-1509.8%) |
| Sept 2019 | - | -$2.03 M(-871.1%) | -$1.84 M(-96.9%) |
| June 2019 | - | $263.00 K(-98.8%) | -$58.45 M(-0.6%) |
| Mar 2019 | - | $21.07 M(-199.6%) | -$58.81 M(-26.4%) |
| Dec 2018 | -$79.89 M(<-9900.0%) | -$21.15 M(-63.9%) | -$79.89 M(+36.0%) |
| Sept 2018 | - | -$58.64 M(>+9900.0%) | -$58.75 M(>+9900.0%) |
| June 2018 | - | -$94.00 K(+452.9%) | -$111.00 K(+552.9%) |
| Mar 2018 | - | -$17.00 K(<-9900.0%) | -$17.00 K(<-9900.0%) |
| Dec 2017 | $0.00 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2017 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2017 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2017 | - | $0.00 | $0.00 |
FAQ
- What is Verrica Pharmaceuticals annual cash flow from investing activities?
- What is the all time high annual CFI for Verrica Pharmaceuticals?
- What is Verrica Pharmaceuticals annual CFI year-on-year change?
- What is Verrica Pharmaceuticals quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Verrica Pharmaceuticals?
- What is Verrica Pharmaceuticals quarterly CFI year-on-year change?
- What is Verrica Pharmaceuticals TTM cash flow from investing activities?
- What is the all time high TTM CFI for Verrica Pharmaceuticals?
- What is Verrica Pharmaceuticals TTM CFI year-on-year change?
What is Verrica Pharmaceuticals annual cash flow from investing activities?
The current annual CFI of VRCA is -$362.00 K
What is the all time high annual CFI for Verrica Pharmaceuticals?
Verrica Pharmaceuticals all-time high annual cash flow from investing activities is $54.04 M
What is Verrica Pharmaceuticals annual CFI year-on-year change?
Over the past year, VRCA annual cash flow from investing activities has changed by -$54.40 M (-100.67%)
What is Verrica Pharmaceuticals quarterly cash flow from investing activities?
The current quarterly CFI of VRCA is -$16.00 K
What is the all time high quarterly CFI for Verrica Pharmaceuticals?
Verrica Pharmaceuticals all-time high quarterly cash flow from investing activities is $43.01 M
What is Verrica Pharmaceuticals quarterly CFI year-on-year change?
Over the past year, VRCA quarterly cash flow from investing activities has changed by +$49.00 K (+75.38%)
What is Verrica Pharmaceuticals TTM cash flow from investing activities?
The current TTM CFI of VRCA is -$254.00 K
What is the all time high TTM CFI for Verrica Pharmaceuticals?
Verrica Pharmaceuticals all-time high TTM cash flow from investing activities is $55.52 M
What is Verrica Pharmaceuticals TTM CFI year-on-year change?
Over the past year, VRCA TTM cash flow from investing activities has changed by -$6.87 M (-103.84%)